Trials / Completed
CompletedNCT01884623
Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer
Multicentric Randomized Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer in Elderly Unfit Patients According to Geriatric Evaluation
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 82 (actual)
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris · Academic / Other
- Sex
- All
- Age
- 70 Years
- Healthy volunteers
- Not accepted
Summary
To test whether cetuximab improves efficacy/tolerance as compared to methotrexate in first line treatment of unfit patients ³ 70 years old with recurrent and /or metastatic HNSCC. Efficacy assessed by failure free survival
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cetuximab | |
| DRUG | Methotrexate |
Timeline
- Start date
- 2013-11-06
- Primary completion
- 2021-10-12
- Completion
- 2021-10-12
- First posted
- 2013-06-24
- Last updated
- 2024-02-09
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01884623. Inclusion in this directory is not an endorsement.